ストックスクリーナーアプリを入手
4.45
4.95%
0.21
アフターアワーズ：
4.45
前日終値:
$4.24
開ける：
$4.23
24時間の取引高:
146.20K
Relative Volume:
0.49
時価総額：
$251.27M
収益：
$2.76M
当期純損益:
$-49.12M
株価収益率:
-2.9667
EPS:
-1.5
ネットキャッシュフロー:
$-46.21M
1週間 パフォーマンス:
+7.49%
1か月 パフォーマンス:
+1.14%
6か月 パフォーマンス:
+53.98%
1年 パフォーマンス:
-21.38%
1日の値動き範囲:
$4.0514
$4.495
1週間の範囲:
$4.0514
$4.495
52週間の値動き範囲:
$2.20
$6.16
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
名前
Orchestra Biomed Holdings Inc
セクター
電話
646-343-9298
住所
150 UNION SQUARE DRIVE, NEW HOPE
OBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.45 | 239.41M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | 開始されました | TD Cowen | Buy |
| 2025-08-20 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-03-20 | 開始されました | BTIG Research | Buy |
| 2025-01-02 | 開始されました | Barclays | Overweight |
| 2024-08-22 | 開始されました | H.C. Wainwright | Buy |
| 2024-07-25 | 開始されました | B. Riley Securities | Buy |
| 2024-01-19 | 開始されました | Jefferies | Buy |
| 2023-02-24 | 開始されました | Piper Sandler | Overweight |
| 2023-02-07 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Orchestra Biomed Holdings Inc (OBIO) 最新ニュース
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Orchestra BioMed (NASDAQ:OBIO) Shares Up 0.2% – Here’s Why - Defense World
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs - Insider Monkey
Orchestra BioMed to Highlight Advancements in Cardiac Therapy at HRS 2025 - MSN
Orchestra BioMed Grants New Hire Stock Options as Clinical Programs Advance - MSN
What drives Orchestra BioMed Holdings Inc stock priceEarnings Beat Highlights & Receive Monthly Expert Trading Blueprints - earlytimes.in
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to NASDAQ Biotechnology Index - marketscreener.com
Can Orchestra BioMed Holdings Inc. stock rebound after recent weakness - Улправда
Why Orchestra BioMed Holdings Inc. stock is in analyst buy zone2025 Top Decliners & Low Risk High Win Rate Stock Picks - Улправда
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates - MSN
Is Orchestra BioMed Holdings Inc. stock a dividend growth opportunityJuly 2025 Rallies & Community Trade Idea Sharing Platform - Улправда
Buyout Rumor: Can Orchestra BioMed Holdings Inc. stock rebound after recent weaknessPortfolio Gains Summary & Capital Protection Trade Alerts - Улправда
What dividend safety score for Orchestra BioMed Holdings Inc. stockWeekly Stock Recap & AI Based Buy/Sell Signal Reports - DonanımHaber
S P Trends: Is Orchestra BioMed Holdings Inc stock a safe buy before earningsQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Why Orchestra BioMed Holdings Inc. stock is favored by top institutionsRisk Management & Growth Focused Investment Plans - Улправда
Will Orchestra BioMed Holdings Inc. stock maintain growth storyDollar Strength & Verified High Yield Trade Plans - Улправда
Can Orchestra BioMed Holdings Inc. stock deliver consistent earnings growthMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - Улправда
How Orchestra BioMed Holdings Inc. stock performs in high volatility marketsJuly 2025 Chart Watch & Growth Focused Stock Pick Reports - bollywoodhelpline.com
Weekly Trades: What dividend safety score for Orchestra BioMed Holdings Inc stockPortfolio Risk Report & Long Hold Capital Preservation Tips - moha.gov.vn
Chmn Hochman Surrenders 43,638 Of Orchestra BioMed Holdings Inc [OBIO] - TradingView — Track All Markets
Orchestra BioMed Holdings, Inc. (OBIO) CFO has 8,670 shares withheld for taxes - Stock Titan
Orchestra BioMed (OBIO) CEO details RSU-related tax share withholding by insider - Stock Titan
Orchestra BioMed (NASDAQ:OBIO) Now Covered by Analysts at TD Cowen - Defense World
TD Cowen Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - Nasdaq
TD Cowen initiates Orchestra BioMed stock with Buy rating on novel medical device portfolio - Investing.com Nigeria
TD Cowen Initiates Orchestra BioMed Holdings at Buy With $15 Price Target - marketscreener.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Orchestra BioMed and Medtronic Unveil Promising Hypertension Therapy Advances - Zenopa
Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting - Investing News Network
Orchestra BioMed announces AVIM Therapy and Virtue SAB Program presentations at ICI Meeting - marketscreener.com
Orchestra BioMed and Medtronic Leadership to Present on Strategic Collaboration for AVIM Therapy at 2025 Innovation in Cardiology Intervention Meeting - Quiver Quantitative
Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements - MSN
What insider trading reveals about Orchestra BioMed Holdings Inc. stockShort Setup & AI Powered Market Trend Analysis - Newser
Orchestra BioMed Enters New Agreement with Terumo for Virtue SAB Device - globallegalchronicle.com
Wall Street Recap: Can Orchestra BioMed Holdings Inc. stock deliver consistent earnings growth2025 Macro Impact & Weekly High Return Stock Forecasts - moha.gov.vn
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy - MSN
12 Hot Penny Stocks to Invest in Right Now - Insider Monkey
A better buy-in window may exist right now for Orchestra BioMed Holdings Inc (OBIO) - Setenews
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Orchestra Biomed announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Orchestra BioMed Grants Stock Options to New Hires as Part of 2025 Inducement Plan - Quiver Quantitative
Orchestra BioMed Holdings Insiders May Regret Not Buying More, Market Cap Hits US$273m - 富途牛牛
Orchestra BioMed’s Big Cash Infusion Sets Stage for High-Stakes Cardiology Trials - MSN
How currency fluctuations impact Orchestra BioMed Holdings Inc. stockDividend Hike & Low Drawdown Trading Strategies - newser.com
Will Orchestra BioMed Holdings Inc. stock outperform tech sector in 2025July 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Orchestra BioMed Study Shows AVIM Therapy Could Transform Care for Hypertensive Heart Disease - MSN
Orchestra Biomed Holdings Inc (OBIO) 財務データ
収益
当期純利益
現金流量
EPS
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):